| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.76% | 27.86% | 27.67% | 29.48% | 34.89% | 35.43% | 28.15% | 28.03% | 33.18% | 32.99% | 33.45% | 36.65% |
| Operating Margin | 9.92% | 8.35% | 5.97% | 11.92% | 20.22% | 17.49% | 11.51% | 11.70% | 13.07% | 13.61% | 11.55% | 15.14% |
| EBITDA Margin | 14.81% | 13.30% | 10.71% | 16.18% | 24.84% | 21.96% | 16.51% | 16.57% | 18.17% | 18.79% | 16.83% | 19.23% |
| Net Margin | 6.28% | 5.73% | 3.44% | 8.60% | 14.75% | 11.13% | 7.13% | 7.80% | 12.15% | 7.59% | 5.03% | 8.50% |
| Current Ratio | 1.42 | 1.44 | 1.17 | 1.50 | 1.92 | 1.66 | 1.12 | 1.51 | 1.31 | 1.36 | 1.57 | 1.73 |
| Quick Ratio | 1.23 | 1.30 | 1.02 | 1.35 | 1.77 | 1.53 | 1.03 | 1.38 | 1.20 | 1.24 | 1.45 | 1.59 |
| Debt / Equity | 0.65 | 0.79 | 0.64 | 0.53 | 0.53 | 0.62 | 0.82 | 0.87 | 0.99 | 1.06 | 1.30 | 1.07 |
| ROE | 10.17% | 9.26% | 5.31% | 12.67% | 23.14% | 16.63% | 10.89% | 12.68% | 18.57% | 13.30% | 8.84% | 18.12% |
| ROA | 4.77% | 4.06% | 2.50% | 6.35% | 11.66% | 7.75% | 4.56% | 5.46% | 7.65% | 5.14% | 3.07% | 7.00% |
| Asset Turnover | 0.76 | 0.71 | 0.73 | 0.74 | 0.79 | 0.70 | 0.64 | 0.70 | 0.63 | 0.68 | 0.61 | 0.82 |
| Book Value / Share | 102.86 | 95.41 | 89.90 | 110.22 | 105.37 | 95.51 | 76.74 | 67.95 | 65.74 | 52.79 | 49.15 | 32.64 |
Labcorp Holdings Inc. is a healthcare diagnostics and laboratory services company that supports physicians, hospitals, pharmaceutical companies, researchers, and patients with clinical testing and scientific insights. Labcorp Holdings Inc. operates through its Diagnostics Laboratories and Biopharma Laboratory Services segments, providing a broad portfolio of routine blood and urine tests as well as specialized services in oncology, genomics, and drug development support. The company maintains an extensive network of patient-service centers and laboratory operations that help deliver testing access, sample processing, and analytical capabilities across the healthcare system. Labcorp Holdings Inc. plays an important role in clinical decision-making, disease detection, and research support by translating laboratory data into information used in patient care and life sciences workflows.